找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Adjuvant Therapy of Breast Cancer; I. Craig Henderson Book 1992 Springer Science+Business Media New York 1992 adjuvant therapy.cell.clinic

[復(fù)制鏈接]
樓主: frustrate
31#
發(fā)表于 2025-3-26 21:36:06 | 只看該作者
Aircraft Prior Based on Primary Radar Data,lue of adjuvant systemic therapy in the management of at least some subsets of these patients has now been widely accepted. These two developments have resulted in many patients being treated with both breast-conserving therapy and adjuvant systemic therapy.
32#
發(fā)表于 2025-3-27 03:59:38 | 只看該作者
Algorithms for Influence Diagramsoposed for palliation of advanced disease or for adjuvant purposes. This approach generally allows the clinician to achieve higher response rates for longer relapse-free periods than with either modality used singly. In spite of these interesting results, it appears that the benefit, at best, is simply additive [.].
33#
發(fā)表于 2025-3-27 07:41:11 | 只看該作者
34#
發(fā)表于 2025-3-27 10:09:44 | 只看該作者
Kanti V. Mardia,Vysaul B. Nyirongong-term survival are almost exclusively dependent upon effective cytotoxic treatments. In diseases such as operable breast cancer, for which adjuvant cytotoxic and endocrine therapies have demonstrated a modest but statistically significant reduction in mortality [.], subjective toxic effects of tre
35#
發(fā)表于 2025-3-27 15:40:40 | 只看該作者
Bayesian Networks and Decision Graphsbeen spilled in debating the best name for a field whose contribution to therapy is still ill defined. Both by virtue of primacy and the existence of a periodic, international conference on ‘neo-adjuvant chemotherapy,’ this term has achieved the widest acceptance. Other terms remain in use, however,
36#
發(fā)表于 2025-3-27 19:59:57 | 只看該作者
37#
發(fā)表于 2025-3-28 00:30:00 | 只看該作者
38#
發(fā)表于 2025-3-28 03:23:23 | 只看該作者
Adjuvant chemotherapy of axillary lymph-node-positive breast cancerf-Erkrankungen besprochen.?.Dieses Lehrbuch richtet sich an Studierende der Ern?hrungswissenschaften, der Biochemie und Molekularbiologie sowie der Biologie. Zahlreiche Farbabbildungen unterstützen die Wissensv978-3-662-65341-8978-3-662-65342-5
39#
發(fā)表于 2025-3-28 07:30:06 | 只看該作者
40#
發(fā)表于 2025-3-28 10:41:49 | 只看該作者
Models for weighing benefits and toxicitieskers to make diet adjustments and ensure the goals of therapy are met..The 2nd edition is an updated and more extensive version covering the nutrition management of IMD, and covers a wide range of t978-3-030-94509-1978-3-030-94510-7
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 03:50
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
浦北县| 西乌珠穆沁旗| 临潭县| 闽侯县| 淄博市| 平塘县| 宣汉县| 芮城县| 明溪县| 揭西县| 阜康市| 长子县| 霍林郭勒市| 西充县| 宁远县| 恩平市| 东源县| 灵璧县| 瓦房店市| 德清县| 武清区| 类乌齐县| 桐柏县| 鸡西市| 延边| 仙桃市| 苍南县| 柞水县| 沅陵县| 黔东| 新乡县| 五台县| 井冈山市| 吴旗县| 永嘉县| 荥阳市| 若羌县| 栾城县| 晋州市| 峨山| 微博|